Literature DB >> 16710312

GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine.

Loic Lhuillier1, Cedric Mombereau, John F Cryan, Klemens Kaupmann.   

Abstract

Exposure to cocaine induces selective behavioral and molecular adaptations. In rodents, acute cocaine induces increased locomotor activity, whereas prolonged drug exposure results in behavioral locomotor sensitization, which is thought to be a consequence of drug-induced neuroadaptive changes. Recent attention has been given to compounds activating GABA(B) receptors as potential antiaddictive therapies. In particular, the principle of allosteric positive GABA(B) receptor modulators is very promising in this respect, as positive modulators lack the sedative and muscle relaxant properties of full GABA(B) receptor agonists such as baclofen. Here, we investigated the effects of systemic application of the GABA(B) receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4, 6-diamine) in animals treated with acute and chronic cocaine administration. Both GS39783 and baclofen dose dependently attenuated acute cocaine-induced hyperlocomotion. Furthermore, both compounds also efficiently blocked cocaine-induced Fos induction in the striatal complex. In chronic studies, GS39783 induced a modest attenuation of cocaine-induced locomotor sensitization. Chronic cocaine induces the accumulation of the transcription factor deltaFosB and upregulates cAMP-response-element-binding protein (CREB) and dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32). GS39783 blocked the induction/activation of DARPP-32 and CREB in the nucleus accumbens and dorsal striatum and partially inhibited deltaFosB accumulation in the dorsal striatum. In summary, our data provide evidence that GS39783 attenuates the acute behavioral effects of cocaine exposure in rodents and in addition prevents the induction of selective long-term adaptive changes in dopaminergic signaling pathways. Further investigation of GABA(B) receptor-positive modulation as a novel therapeutic strategy for the treatment of cocaine dependence and possibly other drugs of abuse is therefore warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710312      PMCID: PMC1774586          DOI: 10.1038/sj.npp.1301102

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  57 in total

Review 1.  CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

Authors:  A J Shaywitz; M E Greenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement.

Authors:  K Brebner; R Phelan; D C Roberts
Journal:  Pharmacol Biochem Behav       Date:  2000-08       Impact factor: 3.533

Review 3.  Molecular structure and physiological functions of GABA(B) receptors.

Authors:  Bernhard Bettler; Klemens Kaupmann; Johannes Mosbacher; Martin Gassmann
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

4.  The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area.

Authors:  H R Olpe; W P Koella; P Wolf; H L Haas
Journal:  Brain Res       Date:  1977-10-14       Impact factor: 3.252

Review 5.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

Authors:  P W Kalivas; J Stewart
Journal:  Brain Res Brain Res Rev       Date:  1991 Sep-Dec

6.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum.

Authors:  A M Graybiel; R Moratalla; H A Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Amplification of dopaminergic signaling by a positive feedback loop.

Authors:  A Nishi; J A Bibb; G L Snyder; H Higashi; A C Nairn; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function.

Authors:  R Z Terwilliger; D Beitner-Johnson; K A Sevarino; S M Crain; E J Nestler
Journal:  Brain Res       Date:  1991-05-10       Impact factor: 3.252

9.  Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.

Authors:  H E Nye; B T Hope; M B Kelz; M Iadarola; E J Nestler
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

10.  Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors.

Authors:  S T Young; L J Porrino; M J Iadarola
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more
  21 in total

1.  Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Authors:  Kimberly A Young; Teresa R Franklin; David C S Roberts; Kanchana Jagannathan; Jesse J Suh; Reagan R Wetherill; Ze Wang; Kyle M Kampman; Charles P O'Brien; Anna Rose Childress
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

2.  The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.

Authors:  J M Wierońska; M Kusek; K Tokarski; J Wabno; W Froestl; A Pilc
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors.

Authors:  Alessandro Orrù; Daniele Fujani; Chiara Cassina; Mirko Conti; Angelo Di Clemente; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

4.  Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats.

Authors:  Robin M Voigt; Amy A Herrold; T Celeste Napier
Journal:  Behav Neurosci       Date:  2011-04       Impact factor: 1.912

Review 5.  Modelling depression in animals: at the interface of reward and stress pathways.

Authors:  D A Slattery; J F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2017-02-22       Impact factor: 4.530

6.  GABAB receptor allosteric modulators exhibit pathway-dependent and species-selective activity.

Authors:  Emmanuel Sturchler; Xia Li; Maria de Lourdes Ladino; Kasia Kaczanowska; Michael Cameron; Patrick R Griffin; M G Finn; Athina Markou; Patricia McDonald
Journal:  Pharmacol Res Perspect       Date:  2017-03-24

7.  Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex.

Authors:  J R Glausier; M Maddox; H C Hemmings; A C Nairn; P Greengard; E C Muly
Journal:  Neuroscience       Date:  2010-02-13       Impact factor: 3.590

Review 8.  Identifying the role of pre-and postsynaptic GABA(B) receptors in behavior.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Neurosci Biobehav Rev       Date:  2015-08-15       Impact factor: 8.989

9.  Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.

Authors:  Xia Li; Victoria B Risbrough; Chelsea Cates-Gatto; Katarzyna Kaczanowska; M G Finn; Amanda J Roberts; Athina Markou
Journal:  Neuropharmacology       Date:  2013-01-29       Impact factor: 5.250

10.  Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.

Authors:  Neil E Paterson; Styliani Vlachou; Sebastien Guery; Klemens Kaupmann; Wolfgang Froestl; Athina Markou
Journal:  J Pharmacol Exp Ther       Date:  2008-04-29       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.